gation from E. coli (pKC1139) or by transfection (KOS305-114), and replacements occurred by stepwise double crossing over as described in Experimental Procedures. It was found that the pKC1139 plasmid as well as the phage were highly unstable in this strain when integrated in the chromosome, and, once a bona fide single crossover was isolated, the second crossover occurred with high frequency (w50%) under nonselective conditions. AT swaps in modules 1, 2, 3, 5, and 7 were constructed in this manner ( Table 2 ). The third approach employed a gene complementation host/vector system in which Red/ET E. coli recombination [38, 39] was used to construct the AT swaps in an expression plasmid (pSET152) containing the gdmA2 and gdmA3 genes and integrated into a ⌬gdmA2A3 deletion strain (see Experimental Procedures). AT replacements in modules 4 and 5 were constructed in this manner ( Table 2) .
Production of Geldanamycin Analogs by AT Swaps
Fermentation broth from each strain grown in production media was analyzed initially by LC-MS. Strains in which new compounds were detected were scaled up, and the abundant compound(s) were purified and characterized by MS and NMR spectroscopies. Func- Table 2 ). The AT substitutions in modules 1, 4, and 5 with rapAT2 all led to the expected analogs, 14-desmethyl-geldanamycin 3, 4, and 7), or methoxymalonyl (modules 2 and 5) ex-(KOSN1877), 8-desmethyl-geldanamycin (KOSN1859), tender unit. Based on the precedent for substituting and 6-desmethoxy-geldanamycin (KOSN1631) (Figure 4 ). methylmalonate and/or methoxylmalonate with maloAll three of these compounds were modified completely nate extender units in the 6-deoxyerythronolide B synby the post-PKS tailoring reactions and were the major thase (DEBS) [28] [29] [30] [31] [32] and the FK520 PKS [33, 34] , it compounds present. A 4,5-dihydro derivative of 6-deswas reasoned that substitutions in which either methylmethoxy-geldanamycin (KOSN1630) was also isolated. malonyl or methoxylmalonyl ATs (i.e., modules 1-5 and Oxidation of the C4-C5 positions is believed to be the 7) were replaced with a malonyl AT would have a high last step of the pathway (see Discussion). The yield of probability of generating productive PKS mutants. The analog in each case was lower (>10-fold) than the rapAT2 domain, used extensively in AT domain swap amount of geldanamycin typically produced by the parexperiments, and/or the rapAT14 domain, both from the ent wild-type strain. Swaps using rapAT14 were also rapamycin PKS [35] , were therefore used to replace the successful in modules 1 and 5 (Table 2 ) with no signifi-AT domains in each of those modules. The boundaries cant differences in production levels compared to the between the AT and surrounding domains (Figure 3 and swaps using rapAT2. Figure 4 ). The combined yield of and 3), or a new set of junctions determined through all three compounds was substantially greater than the optimization experiments (to be reported elsewhere) analogs described above and reached approximately (module 4). These replacements were expected to prohalf of the yield of geldanamycin normally observed. duce 2-desmethyl, 6-desmethoxy, 8-desmethyl, 10-des-KOSN1559 and KOSN1558 were the two most abunmethyl, 12-desmethoxy, and 14-desmethyl geldanadant products, present in roughly equal amounts. Both mycin derivatives.
lack the post-PKS oxidation reactions at C-17 and Three different methods of gene manipulation were C-21 and the double bond at C4-C5. KOSN1558 apdeveloped to make the AT replacements in the geldanapears to result from a polyketide pathway in which the mycin-producing strain, Streptomyces hygroscopicus dehydration of C2-C3, catalyzed by the dehydratase NRRL3602. For two methods, a set of donor cassettes (DH) domain of module 7, does not occur. Finally, was created containing the rapAT2 or rapAT14 cassette KOSN1619 is an analog of KOSN1558 that lacks a carflanked on either side by w1.0-1.3 kb of GdmPKS DNA. bamoyl substituent. Reasons for the incomplete proThese donor cassettes were then moved into either the cessing of these analogs are discussed below. temperature-sensitive plasmid pKC1139 [36] or phage
The AT substitutions that were attempted in modules KOS305-114, an apramycin-resistant derivative of the 2 and 3 did not produce polyketide at detectable levels phage KC515 [37] (described in Experimental Procedures). The donor vectors were introduced by conju- (Table 2 ).
Figure 2. Genetics and Chemistry of Geldanamycin Biosynthesis
Progeldanamycin is the presumed polyketide product of the GdmPKS (encoded by gdmA1, A2, and A3) and GdmF (the lactam-forming amide synthase). The GdmPKS consists of an AHBA loading domain and seven extension modules. Each module catalyzes one round of chain elongation using malonyl-CoA (module 6), methylmalonyl-CoA (modules 1, 3, 5, and 7), or methoxymalonyl-ACP (modules 2 and 6). Each module also modifies the β-carbonyl from each elongation to a hydroxyl (modules 3 and 5), alkene (modules 4 and 7), or methylene (modules 1, 2, and 6). Progeldanamycin is converted to geldanamycin by five steps, the precise order of which has not been determined. (KS-ketosynthase, AT-acyltransferase, DH-dehydratase, ER-enolreductase, KR-ketoreductase, ACP-acyl carrier protein).
Hsp90 Binding and Cytotoxic Activity of Geldanamycin Analogs
Cytotoxicity of the analogs was assessed in SKBr3 cell growth inhibition assays as previously described [19] . All of the compounds tested had substantially greater IC 50 values compared to geldanamycin and 17-AAG (Table 3 ). The compounds also had similar or reduced binding affinity for Hsp90 (Table 3 ). The exception was KOSN1559, which binds to Hsp90 with wfour-fold greater affinity than geldanamycin and weight-fold greater affinity than 17-AAG.
Discussion
One of the major challenges faced with PKS engineering is the difficulty of performing genetic manipulations in the actinomycete or other host organism harboring the PKS gene cluster. This problem can sometimes be overcome by heterologous expression of the gene clus- or those for metabolites containing unusual precursors . Three of the four changes reported here were modified completely by the geldana-S. hygroscopicus. The gene complementation method requires the greatest amount of development effort to mycin post-PKS enzymes. However, the substitution of methyl with hydrogen at C-2 of KOSN1559 has a draconstruct vectors and host strains. However, it also provides the most flexibility and speed once estabmatic impact on the oxidative modifications of the phenol. Disruption of gdmM, encoding a monooxygenase, lished. Therefore, for constructing a large number of PKS gene manipulation experiments, this is the preproduced the 17-demethoxy-21-desoxy derivative of geldanamycin, KOSN1806, which in turn affects formaferred method. In addition to the compounds reported here, the Red/ET cloning method has been used to protion of the C4-C5 double bond to produce the 4,5-dihydro form (unpublished results). No evidence of quinoneduce geldanamycin analogs at the C6 ketone [42] .
Substitution of AT domains has to date provided the containing compounds was found in fermentation extracts of the AT7 substitution. Therefore, it appears greatest number of polyketide analogs produced by modular PKSs. Modification of polyketide structures that compounds lacking the C-2 methyl are very poor substrates for GdmM. The structure of KOSN1559 also through AT engineering allows derivatives to be produced at positions that would otherwise be difficult or supports the conclusion drawn from the gdmM disruption that the post-PKS steps occur in the order of impossible to change by chemical modification. Here, we have altered a methyl or methoxyl group at four carbamate attachment, oxidation of the phenol to the C-17 substituted quinone (the order of these two steps positions of geldanamycin previously unexplored for structure-activity relationship, further demonstrating the is still ambiguous), and formation of the C4-C5 alkene. Both KOSN1558 and KOSN1619 appear to result robustness of this technique for making unique polyketide analogs. Those AT swaps that failed to produce from bypassing of the DH domain in module 7 and transfer of the β-hydroxy intermediate to the downthe desired analog likely resulted from a poor choice in AT boundaries used to create the hybrid. Recent experistream enzyme, GdmF. Again, disruption of activity apparently results from the absence of a methyl substituments have indicated that the location of AT boundaries can make the difference between a functional and nonent, in this case at the α-carbon of the ACP7-bound polyketide intermediate. Bypassing of β-keto processfunctional hybrid [32, 43] . In fact, the AT4 substitution reported here is a result of optimizing the location of the ing activities has been observed previously in engineered PKSs [31] . However, this is believed to be an boundaries from an initially failed swap (details of this work will be reported elsewhere). Therefore, it is expected unprecedented example in which bypassing of an active DH domain has been characterized. Unused DH that the replacements in modules 2 and 3 could be made functional by repositioning the boundaries.
domains have been found often in sequenced PKSs; fications that improve cellular uptake while maintaining [37] . Lysogens were selected on solid R5 using 2 ml of 1 mg/ml enhanced Hsp90 binding affinity of KOSN1559.
. Geldanamycin Analogs Produced by AT Substitutions in the GdmPKS

Replacement of AT Domains in Modules
apramycin overlay. pKC1139 plasmids were introduced into S. hygroscopicus NRRL3602 by conjugation using E. coli ET12657/pUZ8002 as donor Significance [37] . Primary exconjugants were first grown in 5 ml liquid R5 containing 100 mg/l apramycin at 30°C for 2 days. To generate the first 17-AAG, an analog of geldanamycin, is a promising crossover, 0.2 ml of these cells was used to inoculate 5 ml R5 with apramycin and grown at 37°C for 36 hr. This step was repeated anticancer agent that acts through a novel target, tives of pKOS279-69 containing the AT5/rapAT14 and AT4/rapAT2 substitutions, respectively. Both plasmids were constructed using a modified two-step Red/ET cloning procedure [38, 39] . The first Experimental Procedures step introduces a selectable marker with unique restriction sites in pKOS279-69 that are used subsequently to linearize the plasmid Bacterial Strains and Culture Conditions S. hygroscopicus NRRL3602 was the strain used for chromosomal for the second recombination step. For the second step, the linearized recipient plasmid and a linear donor AT cassette are used for substitution of AT domains. Strain K279-248 (gdmA2,gdmA3::neo), used for gene complementation experiments, will be described transformation, thereby selecting for circularized plasmids formed by recombination between the two linear fragments. elsewhere. Plasmids were introduced into S. hygroscopicus by conjugation using E. coli ET12657/pUZ8002 as donor on R5 agar Plasmid pKOS331-178 was constructed as follows. Plasmid pKOS309-6a contains the left and right 1.3 kb fragments flanking plates containing 100 mg/l nalidixic acid. After incubating at 30°C for w16 hr, exconjugants were selected with 3 ml soft nutrient agar the AT5 domain, which are described in the preceding section, joined together at their XbaI sites and inserted between the HindIII containing 1.5 mg apramycin. Liquid cultures were grown in R5 media [37] into E. coli HS996/pSC101/BAD/γβαA (Gene Bridges), and colonies were selected with apramycin and neomycin. Colonies were mycin-production medium (GPM) [2] . Seed cultures were grown in liquid R5 medium for 2 days at 30°C, and 2 ml was used to inocuchecked by restriction enzyme analysis; approximately 60% were found to contain the neo marker recombined at the appropriate late 40 ml of GPM in 250 ml shake flasks at 30°C for 4 days. 85 (d, 3, J = 6.0 Hz), 0.87 (d, 3, J = 6.0 Hz), 1.23 (m, 1), 1.27-1.35  pKOS305-124A, was constructed by inserting the rapAT14 cassette  into the BamHI and PstI restriction sites of pKOS309-6a. A 3.6 kb  (m, 2), 1.29 (s, 3), 1.39 (m, 1), 1.57-1.63 (m, 2), 1.68 (m, 1), 2.19 (m,  1), 2.28 (m, 1), 2.31 (m, 1), 2.41-2.49 (m, 2), 3.09 (m, 1), 3.17 (m, 1),  linear DNA fragment containing the 1.3 kb AT5 left flank, the rapAT14  cassette, and the 1.3 kb AT5 right flank was excised from  3.20 (s, 3), 3.22 (s, 3), 3.32 (m, 1), 3.69 (br s, 1), 3.84 (m, 1) 99 (m, 1), 1.29 (s, 3),  1.24-1.36 (m, 2), 1.49 (m, 1), 1.77 (m, 1), 2.14-2.24 (m, 4) 2, 17.7, 19.2, 26.1, 27.9, 31.6, 32.9, 34.7, 42.9, 56, 58.4 , ml/l) were added to the fermentation broth before filtering. The clarified solution (23 l) was loaded on to a preconditioned HP20 column  72.4, 78.5, 81.2, 81.8, 108.3, 114.3, 118, 122.2, 129.4, 134.2, 138.6,  142.2, 143.7, 156, 157.7 , 6), 1.19 (m, 1), 1.32 (m, 1), 1.38 (m, 1), 1.41 (s, 3), 1.49  (m, 2), 1.56 (m, 1), 1.65 (m, 1), 2.10 (m, 1), 2.28 (m, 1), 2.31 (m, 1) , brown solid. The partially purified compound was further purified by preparative HPLC on a Polaris C-18 column using 60% MeOH 2. 43 (m, 1), 2.47 (m, 1), 3.07 (m, 1), 3.20 (br s, 6), 3.27 (m, 1), 3.38  (m, 1), 3.87 (m, 1), 3.98 (br s, 1), 4.81 (s, 1), 4.91 (s, 1), 5.22 (d, 1, as the mobile phase. KOSN1859 (470 mg) was isolated as a brown solid. J = 8.0 Hz), 6.23 (s, 1), 6.37 (br s, 2), 6.66 (s, 1), 6.87 (s, 1), 9.20 (s,  1), 9.68 (s, 1) d 6 at 39.5 ppm) 12.6, 16.3, 21, 25, 31.9, 32.7, 33.7, 34.4, 42.6, 45.5,  56.1, 57, 67.4, 73.3, 76.9, 79, 81.7, 104.8, 112, 112.7, 130.3, 130.5,  3 , J = 6.0 Hz), 1.11 (s, 3), 1.53 (m, 1), 1.56 (m, 1), 1.83 (m, 1) 21.8, 30.1, 30.9, 35.8, 36.9, 56.4, 57.8, 61.6, 74.0, 77.9, 79.9, 80.6 Herbi-111.4, 125.9, 126.3, 127.3, 127.6, 134.6, 136.8, 137.8, 139.1, 156.0,  mycin B, a new benzoquinonoid ansamycin with anti-TMV and  157.1, 168.2, 184.1, 184 
